|
Q3 2019
Filed on Nov 05, 2019
|
5
|
$186.78 - $221.04
$934 - $1.11K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
350
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
200
|
$25.23 - $50.69
$5.05K - $10.1K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
4,152
|
$11.4 - $16.42
$47.3K - $68.2K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
29
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
238
|
$22.94 - $23.27
$5.46K - $5.54K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
3,083
|
$5.43 - $7.86
$16.7K - $24.2K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
525
|
$7.85 - $15.75
$4.12K - $8.27K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
100
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
45
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
57
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
1,055
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
2,593
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
2,700
|
N/A
|
|
Invesco Exchng Traded Fd Tr
|
Q3 2019
Filed on Nov 05, 2019
|
40
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
234
|
$16.96 - $26.49
$3.97K - $6.2K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
11
|
$66.89 - $90.14
$736 - $992
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
176
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
542
|
$16.73 - $23.11
$9.07K - $12.5K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
174
|
$16.1 - $18.62
$2.8K - $3.24K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
1,322
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
78
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
19
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
19
|
$36.81 - $55.14
$699 - $1.05K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
25
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
39
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
70
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
574
|
$34.44 - $39.52
$19.8K - $22.7K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
266
|
$15.77 - $19.78
$4.19K - $5.26K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
136
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
48
|
$2.29 - $7.1
$110 - $341
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
3,000
|
$4.27 - $6.22
$12.8K - $18.7K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
44
|
$45.52 - $55.5
$2K - $2.44K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
184
|
$48.46 - $58.02
$8.92K - $10.7K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
388
|
$17.74 - $20.29
$6.88K - $7.87K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
32
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
85
|
$43.41 - $52.14
$3.69K - $4.43K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
23
|
$153.66 - $201.07
$3.53K - $4.62K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
248
|
$111.71 - $113.96
$27.7K - $28.3K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
300
|
$15.97 - $19.77
$4.79K - $5.93K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
14
|
$17.01 - $24.58
$238 - $344
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
245
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
42
|
$74.39 - $80.59
$3.12K - $3.38K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
575
|
$27.2 - $34.41
$15.6K - $19.8K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
48
|
$9.7 - $16.22
$466 - $779
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
340
|
$41.75 - $48.73
$14.2K - $16.6K
|
|
Contravir Pharmaceuticals In
|
Q3 2019
Filed on Nov 05, 2019
|
1
|
N/A
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
433
|
$7.33 - $7.98
$3.17K - $3.46K
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
24
|
$19.85 - $22.76
$476 - $546
|
|
|
Q3 2019
Filed on Nov 05, 2019
|
642
|
$9.68 - $9.81
$6.21K - $6.3K
|
|